This study is testing the safety and early effectiveness of an experimental drug called Kamuvudine-8 (K8) for people with geographic atrophy, an advanced form of age-related macular degeneration that causes permanent vision loss. Up to 30 participants will receive injections of t…
Phase: PHASE1, PHASE2 • Sponsor: Michelle Abou-Jaoude • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC